Keratin 17 is overexpressed and predicts poor survival in estrogen receptor–negative/human epidermal growth factor receptor-2–negative breast cancer

Ross D. Merkin, Elizabeth A. Vanner, Jamie L. Romeiser, A. Laurie W. Shroyer, Luisa F. Escobar-Hoyos, Jinyu Li, Robert S. Powers, Stephanie Burke, Kenneth R. Shroyer

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Keratin 17 is overexpressed and predicts poor survival in estrogen receptor–negative/human epidermal growth factor receptor-2–negative breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences